Defining the in vivo physiology of E. coli O157:H7 in cattle to improve phage-based interventions
Lead Research Organisation:
MOREDUN RESEARCH INSTITUTE
Department Name: Disease Control
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
E. coli O157 is part of a unique group of bacterial pathogens that intimately attach to the outside of host cells as their main colonisation strategy. They employ a type 3 secretion system to inject effector proteins that result in remodelling of the actin cytoskeleton and silencing of innate cellular responses. The bacteria also inhibit host cell apoptosis to keep these 'base camp' cells alive and this is enabled by Shiga toxin which limits local proliferation of new epithelial cells. T3S and intimate attachment are essential for colonisation of the bovine reservoir host and excretion from cattle directly or indirectly can lead to severe human infections. Our grouping has been studying the biology of this zoonotic pathogen in the bovine host for the last two decades and we now want to dissect E. coli O157 gene expression at the main site of colonisation in cattle, the terminal rectum, to advance phage-based interventions. We will carry out RNAseq on O157 sampled from experimentally infected cattle. We will compare this expression with bacteria grown in mucus and intimately attached to cultured bovine epithelial cells. We propose that by understanding the expression 'states' of the bacteria in vivo, it will facilitate selecting bacteriophages active on E. coli O157 when colonising cattle. The second main aim of the research will be defining the bacterial surface receptors used by phage active on E. coli O157 under these specific growth conditions. By combining the expression and phage activity information we will be able to select phage combinations likely to be effective in vivo. The final part of the research will be to test phage formulations in cattle colonised by E. coli O157. An understanding of the in vivo of physiology of this public health threat is important for the design of any cattle-based intervention. The approach being taken to optimise phage treatments in this study can be applied to other important bacterial infections.
| Description | Scottish Public Health Microbiology Strategic Oversight and Assurance Board |
| Geographic Reach | National |
| Policy Influence Type | Participation in a guidance/advisory committee |
| Description | Summer Student Dairy Research - 'Development of a multi species phage cocktail to treat bovine mastitis' |
| Amount | £4,500 (GBP) |
| Organisation | Hannah Dairy Research Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2025 |
| End | 08/2025 |
| Description | Summer Student Dairy Research - 'Development of a phage treatment for raw milk to improve safety of unpasteurised cheese' |
| Amount | £4,500 (GBP) |
| Organisation | Hannah Dairy Research Foundation |
| Sector | Charity/Non Profit |
| Country | United Kingdom |
| Start | 05/2024 |
| End | 08/2024 |
| Title | Bovine rectal tissue biopsies for studying Escherichia coli O157 colonisation |
| Description | Pinch biopsies were harvested from the recto-anal junction (RAJ) of animals colonised by E. coli O157. All biopsies were stored in RNA later. Biopsies were used to establish standard operating procedures (SOPs) for RNA extraction E. coli O157 when colonising the RAJ. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2024 |
| Provided To Others? | No |
| Impact | SOPs were developed to efficiently extract E. coli O157 RNA when colonising at the bovine RAJ. These SOPs will facilitate RNA extractions and subsequent RNA-seq experiments. |
| Description | Efficacy testing of natural products as potential anti-virulence therapy against Escherichia coli O157 |
| Organisation | University of Glasgow |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | As part of this collaboration we will provide BSL-3 training and use of BSL-3 laboratories. We will also provide expertise in Escherichia coli O157 pathogenesis, BSL-3 experimental design and wildtype Escherichia coli O157 isolates. |
| Collaborator Contribution | Collaborators will provide lead natrual products with potential anti-virulence properties for testing. All work will be carried out by UofG BBSRC fellow once BSL-3 trained. |
| Impact | No outputs to date |
| Start Year | 2024 |
| Description | STEC O157 Epidemiology and control |
| Organisation | National Institute of Agricultural Technology |
| Country | Argentina |
| Sector | Public |
| PI Contribution | Establishment of an international working group focused on STEC epidemiology, genomics and control. Attended workshop in 2023 participation in working group activities. |
| Collaborator Contribution | Organised first working group meeting on STEC epidemiology, genomics and control, and established on-line forum for knowledge exchange. |
| Impact | Working group established on STEC epidemiology, genomics and control, including on-line forum for knowledge exchange between Argentinian, UK and US partners. |
| Start Year | 2023 |
| Description | International working group on STEC diversity and control |
| Form Of Engagement Activity | A formal working group, expert panel or dialogue |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Industry/Business |
| Results and Impact | This international worknig group meeting held in Argentina brought together research scientists, medical professionals, agricultural industry representatives and policy makers from the UK, and North and South America to discuss the role intensification of ruminant farming systems plays in the epidemiology of STEC and how to control this through on-farm interventions. This resulted in an action plan for future research activities to better understand which farming systems are best for STEC control, and how to develop and deploy interventions such as altered feeding, vaccination, and phage therapy. |
| Year(s) Of Engagement Activity | 2023 |
